Bernd Kinzel
Novartis (Switzerland)(CH)Novartis Institutes for BioMedical Research
Publications by Year
Research Areas
Hearing, Cochlea, Tinnitus, Genetics, Sphingolipid Metabolism and Signaling, MicroRNA in disease regulation, NF-κB Signaling Pathways, Epigenetics and DNA Methylation
Most-Cited Works
- → Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension(2015)498 cited
- → LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice(2011)365 cited
- → The RSPO–LGR4/5–ZNRF3/RNF43 module controls liver zonation and size(2016)350 cited
- → Flow-Regulated Endothelial S1P Receptor-1 Signaling Sustains Vascular Development(2012)320 cited
- → Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720(2005)262 cited
- → Redistribution of GABAB(1)Protein and Atypical GABABResponses in GABAB(2)-Deficient Mice(2004)226 cited
- → YAP, but Not RSPO-LGR4/5, Signaling in Biliary Epithelial Cells Promotes a Ductular Reaction in Response to Liver Injury(2019)208 cited
- → FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone(2011)146 cited
- → Deficiency of MALT1 Paracaspase Activity Results in Unbalanced Regulatory and Effector T and B Cell Responses Leading to Multiorgan Inflammation(2015)126 cited
- → Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels(2014)121 cited